The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients

Clinical Nephrology

Volumn 75, Issue 6, 2011, Pages 491-496

  Gungor, O ^a   Kircelli, F ^a   Carrero, J J ^b   Hur, E ^a   Demirci, M S ^a   Asci, G ^a   Toz, H ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arterial stiffness; Calcineurin inhibitors; Immunosuppressive drug; MTOR inhibitors; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; OSTEOCALCIN; RAPAMYCIN; TACROLIMUS; CALCINEURIN; CALCIUM BINDING PROTEIN; CHOLESTEROL; CREATININE; IMMUNOSUPPRESSIVE AGENT; MATRIX GLA PROTEIN; MTOR PROTEIN, HUMAN; SCLEROPROTEIN; TARGET OF RAPAMYCIN KINASE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CAROTID ARTERY PULSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROTEINURIA; PULSE WAVE; QUANTITATIVE ANALYSIS; RISK FACTOR; ADOLESCENT; AGE; ANALYSIS OF VARIANCE; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERY; CROSS-SECTIONAL STUDY; DRUG ANTAGONISM; ELECTROCARDIOGRAPHY; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCINEURIN; CALCIUM-BINDING PROTEINS; CAROTID ARTERIES; CHOLESTEROL; CREATININE; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FEMORAL ARTERY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINURIA; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 79960942835     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75491     Document Type: Article

References (22)

1. Lentine KL, Hurst FP, Jindal RM, Villines TC, Kunz JS, Yuan CM, Hauptman PJ, Abbott KC. Cardiovascular risk assesment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis. 2010; 55: 152-167.
2. Covic A, Gusbeth-tatomir P, Goldsmith DJ. Arterial stiffness in renal patients: an update.AmJ Kidney Dis. 2005; 45: 965-977.
3. Bahous SA, Blacher J, Safar ME. Aortic stiffness, kidney disease, and renal transplantation. Curr Hypertens Rep. 2009; 11: 98-103.
4. Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010; 31: 214-221.
5. Stompór T, Rajzer M, Kawecka-Jaszcz K, Dembinska-Kiec A, Janda K, Wójcik K, Tabor B, Zdzienicka A, Grzybowska EJ, Sulowicz W. Renal transplantation ameliorates the progression in patients treated with peritoneal dialysis. Perit Dial Int. 2005; 25: 492-496.
6. Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, Pastural-Thaunat M, Tricot L, Kolko-Labadens A, Karras A, Haymann JP. Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol. 2008; 19: 798-805.
7. Kneifel M, Scholze A, Burkert A, Offerman G, Rothermund L, Zidek W, Tepel M. Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant. 2006; 6: 1624-1630.
8. Mulay AV, Cockfield S, Stryker R, Fergusson D, Knoll GA. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic rewiev of the evidence. Transplantation. 2006; 82: 1153-1162.
9. Seckinger J, Sommerer C, HinkelUP, Hoffmann O, Zeier M, Schwenger V. Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens. 2008; 26: 2213-2219.
10. Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZAl. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J AmSoc Nephrol. 2010; 5: 568-575.
11. Van Summeren MJ, Hameleers JM, Schurgers LJ, Hoeks AP, Uiterwall CS, Krüger T, Vermeer C, Kuis W, Lilien MRl. Circulating calcification inhibitors and vascular properties in children after renal transplantation. Pediatr Nephrol. 2008; 23: 985-993.
12. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995; 26: 485-490.
13. Khosdel AR, Carney SL. Arterial stiffness in kidney transplant recipients: an overview of methodology and applications. Urol J. 2008; 5: 3-14.
14. Martinez-Castelao, Sarrias X, Bestard O, Gil-Vernet S, Seron D, Cruzado JM, Moreso F, Diez-Noguera A, Grinyo JM. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression. Transplant Proc. 2005; 37: 3788-3790.
15. Opazo Saez A, Kos M, Witzke O, Kribben A, Nürnberger J. Effect of new-onset diabetes mellitus on arterial stiffness in renal transplantation. Transpl Int. 2008; 21: 930-935.
16. Zhan WW, Chen YH, Zhang YF, Zhu Y, Lin YY, Ren XP, Li XY, Liu YP. Carotid stiffness and microalbuminuria in patients with type 2 diabetes. Endocrine. 2009; 35: 409-413.
17. Payne RA, Wilkinson IB, Webb DJ. Arterial stiffness and hypertension: emerging concepts. Hypertension. 2010; 55: 9-14.
18. Keven K, Calayoglu R, Sengul S, Dincer I, Kutlay S, Erturk S, Erbay B, Nergizoglu G. Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index. Clin Transplant. 2008; 22: 360-365.
19. Cranenburg EC, Brandenburg VM, Vermeer C, Stenger M, Mühlenbruch G, Mahnken AH, Gladziwa U, Ketteler M, Schurgers LJ. Uncarboxylated matrix gla protein (ucMGP) is associated with coronary artery calcification in hemodialysis patients. Thromb Haemost. 2009; 10: 359-366.
20. Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers. Undercarboxylated matrixGLAorotein levels are decreased in dialysis patients and related to parameters of calciumphosphate metabolsim and aortic augmentation index. Blood Purif. 2007; 25: 395-401.
21. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L. The circulating calcification inhibitors, fetuin-A and osteoprotogerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant. 2008; 23: 3263-3271.
22. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008; 100: 593-603.